As of November 6, 2026, Corcept Therapeutics Inc. is a publicly traded company (Nasdaq: CORT); its largest reported holder is BlackRock, with 8.9% on Schedule 13G/A of October 27, 2026, then Ingalls & Snyder LLC (6.8%). The largest insider holding is G. Leonard Baker Jr., a director, with 5,550,196 shares (5.1% of shares outstanding), per Form 4 of March 19, 2026 (Schedule 13G/A, October 27, 2026).
Is this your company?
About to sign with, pay or invest in Corcept Therapeutics Inc.? See the free Snapshot first.
Free to see. No signup.
Is Corcept Therapeutics Inc. a real, registered company?
- Corcept Therapeutics Incorporated files with the SEC under CIK 1088856 (its SEC filings).
- Its shares are listed under the ticker CORT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Redwood City, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CORCEPT THERAPEUTICS INCORPORATED in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Sean Maduck, President (Form 8-K filed 2026-09-23). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-10-27).
Who are Corcept Therapeutics Inc.'s owners and officers?
Corcept Therapeutics Inc.: incorporated in Delaware; business address in Redwood City, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-27 | Blackrock, Inc. | 8.9% |
| Schedule 13G/A, 2026-08-13 | Renaissance Technologies LLC | 4.9% |
| Schedule 13G/A, 2026-04-21 | Ingalls & Snyder LLC | 6.8% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-12 | Renaissance Technologies LLC | 5.47% |
| Schedule 13G/A, 2025-07-17 | Blackrock, Inc. | 10.9% |
Questions about who owns Corcept Therapeutics Inc.
Who owns Corcept Therapeutics Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Corcept Therapeutics Inc.: Blackrock, Inc. (8.9%, Schedule 13G/A, filed 2026-10-27) and Ingalls & Snyder LLC (6.8%, Schedule 13G/A, filed 2026-04-21).
Who are the largest shareholders of Corcept Therapeutics Inc.?
By the share each holder's latest filing reports, the largest holders of Corcept Therapeutics Inc. on this page are Blackrock, Inc. (8.9%) and Ingalls & Snyder LLC (6.8%).
When did Blackrock, Inc. buy into Corcept Therapeutics Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2025-07-17, reporting 10.9%; its latest, Schedule 13G/A filed 2026-10-27, reports 8.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Corcept Therapeutics Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Corcept Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Corcept Therapeutics Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-23 | Sean Maduck | President | departed | 2026-10-01 |
Which insiders own Corcept Therapeutics Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 5,550,196 shares (5.1% of shares outstanding), 1,146,631 held directly and 4,403,565 indirectly (Form 4, 2026-03-19).
- , the chief executive and a director: 2,865,489 shares (2.6% of shares outstanding), held indirectly through a joseph k. belanoff and katherine a. blenko revocable living trust dtd 04/29/02 (Form 4, 2026-06-02).
- , a director: 1,454,543 shares (1.3% of shares outstanding), held indirectly through a james n. wilson and pamela d. wilson trust (Form 4, 2026-10-16).
- , a director: 1,159,686 shares (1.1% of shares outstanding), held indirectly through a held by david l. mahoney and winnifred c. ellis 1998 family trust (Form 4, 2026-08-20).
- , the chief scientific officer: 255,437 shares (0.23% of shares outstanding) (Form 4, 2026-02-11).
Shares outstanding: 109,443,109 as of 2026-10-22, from the company's latest SEC cover page.
How much has Corcept Therapeutics Inc. raised?
No fundraising or offering filing from Corcept Therapeutics Inc. is on file with us.
Keep reading
More on Corcept Therapeutics Inc. and the records around it.
Corcept Therapeutics Inc. elsewhere on the record
- Leadership changes Sep 2026
Companies that share a holder
- Renaissance Technologies LLC also filed stake reports on 46 other companies: AMERICAN PUBLIC EDUCATION INC (Aug 2026), Bolt Biotherapeutics, Inc. (Aug 2026), Commercial Vehicle Group, Inc. (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/corcept-therapeutics